| Literature DB >> 24959401 |
Petra Olejníková1, L'ubomír Svorc2, Denisa Olšovská1, Anna Panáková1, Zuzana Vihonská1, Katarína Kovaryová1, Stefan Marchalín3.
Abstract
The antimicrobial activity of 3-methyl-5-isopropyl (or ethyl) 6-methyl-4-nitrophenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives was evaluated. Prokaryotes (bacteria) appeared to be more sensitive to their antimicrobial activity than were eukaryotes (filamentous fungi). The best antibacterial activity was shown by derivative 33, which was able to inhibit the growth of Mycobacterium smegmatis (MIC33 = 9 μg.ml(-1)), Staphylococcus aureus (MIC33 = 25 μg.ml(-1)), and Escherichia coli (MIC33 = 100 μg.ml(-1)). In addition, derivative 4 demonstrated its antibacterial power on the acid-fast bacterial species M. smegmatis and on Gram-positive S. aureus. Focusing on the structure-activity relationship, it appears that the increase in the substituent bulk at the C2 position improved the antibacterial activity of the set of compounds studied. Derivatives 33 and 4, carrying 2-cyano-3-oxo-3-phenylprop-1-en-1-yl and allyliminomethyl groups, respectively, showed significantly higher inhibition activities on all tested microorganisms in comparison with the rest of the derivatives. This enhancement was also in good correlation with different log P values (lipophilicity parameter).Entities:
Keywords: 1,4-Dihydropyridine derivatives; Antibacterial activity; Antifungal activity; Lipophilicity
Year: 2014 PMID: 24959401 PMCID: PMC4065119 DOI: 10.3797/scipharm.1311-04
Source DB: PubMed Journal: Sci Pharm ISSN: 0036-8709
Fig. 1Synthesis of 5-isopropyl 3-methyl 2-[(allylimino)methyl]-6-methyl- 4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Antibacterial activity of 1,4-DHP derivatives expressed by MIC and IC50 (μg/ml) evaluated by the broth microdilution method
| model bacteria | ||||||
|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
| tested cpd. | MIC | IC50 | MIC | IC50 | MIC | IC50 |
| 100s | 75 | 50s | 9 | > 100 | > 100 | |
| 9s | 3 | 25s | 9 | 100s | 50 | |
| > 100 | 56 | 30s | 12 | > 100 | > 100 | |
| 100s | 25 | > 100 | > 100 | > 100 | > 100 | |
| > 100 | > 100 | > 100 | > 100 | > 100 | > 100 | |
| 50s | 31 | 25s | 12 | > 100 | > 100 | |
s…bacteriostatic effect on the bacterial growth.
Growth of model filamentous fungi in the presence of 1,4-DHP derivatives tested at the concentration of 100 μg/ml
| Model fungi | |||||
|---|---|---|---|---|---|
|
| |||||
| Growth (%) | |||||
|
| |||||
| Tested cpd. | |||||
| 7 | 80 | 100 | 40 | 70 | 100 |
| 33 | 70 | 100 | 50 | 100 | 100 |
| 5 | 100 | 65 | 100 | 80 | 100 |
| 6 | 100 | 65 | 70 | 100 | 100 |
| U | 100 | 100 | 100 | 100 | 100 |
| 4 | 70 | 70 | 80 | 100 | 100 |
…Growth inhibition of the fungus was observed at the concentration range of 25–100 μg/ml;
…Growth inhibition of the fungus was observed at the concentration range of 50–100 μg/ml.
Fig. 2Growth of M. smegmatis (A) and S. aureus (B) in the presence of 1,4-DHP derivatives in the concentration 25 μg/ml
Fig. 3Calculated lipophilicity and binding energy values for 1,4-DHP derivatives studied
Set of 1,4-DHP derivatives tested for antimicrobial activity
| Cpd. Nr. | 1,4-DHP derivative | Structural derivative name [published in] |
|---|---|---|
|
| 5-isopropyl 3-methyl 2-[(allylimino)methyl]-6-methyl-4-(3-nitrophenyl)-1,4-dihydro-pyridine-3,5-dicarboxylate | |
|
| (E)-5-isopropyl 3-methyl 2-(2-cyano-3-oxo-3-phenylprop-1-enyl)-6-methyl-4-(3-nitro-phenyl)-1,4-dihydropyridine-3,5-dicarbo-xylate | |
|
| 5-isopropyl 3-methyl 2-carbamoyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
|
| 5-isopropyl 3-methyl 2-(dimethoxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
|
| 5-ethyl 3-methyl 2-(dimethoxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
|
| 3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-2-carboxylic acid |